Edwards Lifesciences CorporationEWNYSE
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
0.66%
↓ 66% below average
Average (9y)
1.95%
Historical baseline
Range
High:3.47%
Low:0.66%
CAGR
-14.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 0.66% | -51.9% |
| 2023 | 1.36% | -34.1% |
| 2022 | 2.06% | +18.9% |
| 2021 | 1.74% | +52.5% |
| 2020 | 1.14% | -38.6% |
| 2019 | 1.85% | -13.3% |
| 2018 | 2.14% | -38.4% |
| 2017 | 3.47% | +42.3% |
| 2016 | 2.44% | -6.3% |
| 2015 | 2.60% | - |